This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
HIV Infections
and you are
between 18 and 50
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

HVTN 908 is a sub study of the HIV vaccine trial, HVTN 205. The purpose of this sub study is to better understand how a person's immune system responds to vaccines, particularly HIV vaccines. More specifically, researchers will determine whether early responses in the immune system help predict strong and long-lasting immunity.

Provided treatments

  • Biological: JS7 DNA vaccine
  • Biological: MVA/HIV62 vaccine
Tris trial is registered with FDA with number: NCT00908323. The sponsor of the trial is National Institute of Allergy and Infectious Diseases (NIAID) and it is looking for 47 volunteers for the current phase.
Official trial title:
Characterization of the Innate Immune Response to Candidate HIV Vaccines, an Ancillary Study to HVTN 205